Our study clearly demonstrated that USP35 promotes the growth of ER+ breast cancer cells in vitro and in vivo, which is consistent with higher USP35 expression in breast tumors compared with adjacent normal breast tissues (Figs. 1a, d). The gene discussed is USP35; the disease is breast cancer.